NEW YORK (GenomeWeb) – Monsanto announced two new licensing agreements for genome editing technologies with Israel's TargetGene Biotechnologies and Germany's Nomad Bioscience.

Under the terms of the TargetGene agreement, Monsanto has obtained an exclusive license to the firm's genome editing engine (T-Gee) and an equity position in the privately owned firm. T-Gee is based on RNA-directed gene targeting, the firms said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.